ArticleHarm reduction journal2020
Factors associated with drug checking service utilization among people who use drugs in a Canadian setting.
Article in Harm reduction journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 40 citations in OpenAlex.
- Discordant Drug Checking Results and Risk Reduction Behaviours: Findings From the ChecKnow Study in France.Drug and alcohol review · 2026Article
- Risk reduction behaviours following the detection of unexpected drugs through community drug checking: a cross-sectional study.Harm reduction journal · 2026Article
- Unintentional benzodiazepine use and frequency of drug checking service utilization: a cross-sectional study.Harm reduction journal · 2026Article
- Real time, on-site drug checking in low-threshold housing communities.Harm reduction journal · 2026Article
- Impact of having a regular drug dealer on obtaining drug checking results consistent with expectations during a drug toxicity crisis in a Canadian setting.Drug and alcohol dependence · 2025Article
- 'It'd Be Nice to Know if You're About to Have Drain Cleaner': A Qualitative Study of Preferred Drug Checking Service Features to Inform the Design of CheQpoint, Queensland's First Fixed-Site Drug Checking Service.Drug and alcohol review · 2025Article
- Utilization of drug checking services in Austria: a cross-sectional online survey.Harm reduction journal · 2025Article
- "If everyone knew about this, how many lives could we save?": Do drug suppliers have a role in reducing overdose risk?Drug and alcohol dependence reports · 2024Article
- How do we understand the value of drug checking as a component of harm reduction services? A qualitative exploration of client and provider perspectives.Harm reduction journal · 2024Article
- Planning and implementing community-based drug checking services in Scotland: a qualitative exploration using the consolidated framework for implementation research.Substance abuse treatment, prevention, and policy · 2024Article
- A survey of North American drug checking services operating in 2022.The International journal on drug policy · 2023Article
- Drug checking in the fentanyl era: Utilization and interest among people who inject drugs in San Diego, California.The International journal on drug policy · 2023Article
- 'It's not going to be a one size fits all': a qualitative exploration of the potential utility of three drug checking service models in Scotland.Harm reduction journal · 2023Article
- Examining fentanyl and its analogues in the unregulated drug supply of British Columbia, Canada using drug checking technologies.Drug and alcohol review · 2023Article
- Article
- A Realist Review of How Community-Based Drug Checking Services Could Be Designed and Implemented to Promote Engagement of People Who Use Drugs.International journal of environmental research and public health · 2022Review
- Development of a Graphene-Oxide-Deposited Carbon Electrode for the Rapid and Low-Level Detection of Fentanyl and Derivatives.Analytical chemistry · 2022Article
- Take-home drug checking as a novel harm reduction strategy in British Columbia, Canada.The International journal on drug policy · 2022Article
- The Bronze Age of drug checking: barriers and facilitators to implementing advanced drug checking amidst police violence and COVID-19.Harm reduction journal · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 4 institutions in 1 country.
Funding
Abstract
backgroundThe United States and Canada are amidst an opioid overdose crisis, with the Canadian province of British Columbia (BC) among the hardest hit. In response, drug checking services (DCS) have been introduced in this setting as a novel pilot harm reduction intervention though little is known about usage rates. Therefore, we sought to identify factors associated with drug checking uptake among people who use drugs (PWUD) in Vancouver, BC.
methodsData were derived from three ongoing prospective cohort studies of PWUD in Vancouver between June and November 2018. Multivariable logistic regression was used to determine factors associated with self-reported DCS utilization in the past 6 months among participants at high risk of fentanyl exposure (i.e., those self-reporting illicit opioid use or testing positive for fentanyl via urine drug screen).
resultsAmong 828 eligible participants, including 451 (55%) males, 176 (21%) reported recent use of DCS. In multivariable analyses, factors significantly associated with DCS utilization included: homelessness (Adjusted Odds Ratio [AOR] 1.47; 95% Confidence Interval [CI] 1.01-2.13) and involvement in drug dealing (AOR 1.59; 95% CI 1.05-2.39).
conclusionsIn our sample of PWUD, uptake of DCS was low, although those who were homeless, a sub-population known to be at a heightened risk of overdose, were more likely to use the services. Those involved in drug dealing were also more likely to use the services, which may imply potential for improving drug market safety. Further evaluation of drug checking is warranted.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.